Patent classifications
C07D251/12
DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME
The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.
DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME
The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.
SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME
The present specification provides a compound having a spiro structure, and an organic light emitting device including the same.
Composition for forming organic film, display device using the composition, and method of manufacturing the display device
A composition for forming organic film, a display device utilizing the composition, and a method of manufacturing the display device are provided. The composition for forming an organic film includes a solvent; and a compound of Formula 1:
ArR).sub.k. Formula 1
Composition for forming organic film, display device using the composition, and method of manufacturing the display device
A composition for forming organic film, a display device utilizing the composition, and a method of manufacturing the display device are provided. The composition for forming an organic film includes a solvent; and a compound of Formula 1:
ArR).sub.k. Formula 1
BTK INHIBITOR
- Xuehai Wang ,
- Chengde Wu ,
- Yong XU ,
- Chunli Shen ,
- Li'e Li ,
- Guoping Hu ,
- Yang Yue ,
- Jian Li ,
- Diliang Guo ,
- Nengyang Shi ,
- Lu Huang ,
- Shuhui Chen ,
- Ronghua Tu ,
- Zhongwen Yang ,
- Xuwen Zhang ,
- Qiang Xiao ,
- Hua Tian ,
- Yanping Yu ,
- Hailiang Chen ,
- Wenjie Sun ,
- Zhenyu He ,
- Jie Shen ,
- Jing Yang ,
- Jing Tang ,
- Wen Zhou ,
- Jing Yu ,
- Yi Zhang ,
- Quan Liu
Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
##STR00001##
BTK INHIBITOR
- Xuehai Wang ,
- Chengde Wu ,
- Yong XU ,
- Chunli Shen ,
- Li'e Li ,
- Guoping Hu ,
- Yang Yue ,
- Jian Li ,
- Diliang Guo ,
- Nengyang Shi ,
- Lu Huang ,
- Shuhui Chen ,
- Ronghua Tu ,
- Zhongwen Yang ,
- Xuwen Zhang ,
- Qiang Xiao ,
- Hua Tian ,
- Yanping Yu ,
- Hailiang Chen ,
- Wenjie Sun ,
- Zhenyu He ,
- Jie Shen ,
- Jing Yang ,
- Jing Tang ,
- Wen Zhou ,
- Jing Yu ,
- Yi Zhang ,
- Quan Liu
Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
##STR00001##
CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME
The present specification relates to a cyclic compound and an organic light emitting device comprising the same.
Double-spiro type compound and organic light-emitting device containing same
The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.
Double-spiro type compound and organic light-emitting device containing same
The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.